The Basque biotechnology company Biotechnology Institute (BTI) took advantage of its 7th Annual Symposium, held on 12 and 13 September in Bilbao, to present its new facial rejuvenation technique, based on infiltrations into the face of enriched plasma obtained from the patients themselves.

The BTI researchers Eduardo Anitua, Isabel Andia and Mikel Sánchez developed PRGF (Plasma Rich in Growth Factors) technology almost a decade ago. This technique enables the creation of an autologous material (i.e. created from the patient’s own blood and, therefore, with no adverse effects) for application in diverse therapeutic areas.

The aim of the PRGF technology is to achieve successful applications in areas such as oral implantology, oral and maxillo-facial surgery, orthopaedics, ophthalmology, sports medicine, chronic ulcer treatment and, more recently, dermatology.

The research launched by BTI in the dermatology field has recently successfully passed the clinical testing process. The conclusions drawn from these tests indicate that the enriched cells produce endogenous collagen and synthesise hyaluronic acid from the organism itself, thereby substantially improving the smoothness, thickness, hydration and, consequently, health of the skin. This plasma is obtained entirely from the blood of each patient and favour facial rejuvenation with spectacular results.

The 7th Biotechnology Institute (BTI) Annual Symposium, which was held on 12 and 13 September at the Palacio Euskalduna in Bilbao, was able to count on the presence of leading national and international lecturers and speakers, and brought together 1,800 medical specialists from more than 20 countries.